Inventor
CAMPBELL-CRAWFORD MATTHEW HOWARD JAMES
GB7 patents
Patents
7 patentsUS10513517B2Dec 24, 2019
Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases
GLAXOSMITHKLINE IP DEV LTD11 citations82
US10144733B2Dec 4, 2018
Naphthyridine derivatives as alpha v beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases
GLAXOSMITHKLINE IP DEV LTD5 citations71
US10004724B2Jun 26, 2018
Compounds alpha v beta 6 integrin antagonists
GLAXOSMITHKLINE IP DEV LTD2 citations71
US10487080B2Nov 26, 2019
Naphthyridines as integrin antagonists
GLAXOSMITHKLINE IP DEV LTD3 citations70
US10000489B2Jun 19, 2018
Compounds αvβ6 integrin antagonists
GLAXOSMITHKLINE IP DEV LTD5 citations70
US9956209B2May 1, 2018
Compounds αv β6 integrin antagonists
GLAXOSMITHKLINE IP DEV LTD4 citations70
US10342783B2Jul 9, 2019
Compounds αvβ6 integrin antagonists
GLAXOSMITHKLINE IP DEV LTD1 citations59